| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing botulinum toxin type B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Botulinum toxin type B |
Inferred relationship |
Some |
1 |
| Clostridium botulinum-toxin type B 5000 enheder/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Botulinum toxin type B |
Inferred relationship |
Some |
|
| Clostridium botulinum-toxin type B 5000 enheder/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Botulinum toxin type B |
Inferred relationship |
Some |
|
| Clostridium botulinum-toxin type B 5.000 enheder/ml, opløsning til injektion, ampul a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Botulinum toxin type B |
Inferred relationship |
Some |
|
| Foodborne botulism, type B (disorder) |
Causative agent |
True |
Botulinum toxin type B |
Inferred relationship |
Some |
1 |
| RimabotulinumtoxinB (substance) |
Is a |
False |
Botulinum toxin type B |
Inferred relationship |
Some |
|
| Product containing only botulinum toxin type B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Botulinum toxin type B |
Inferred relationship |
Some |
1 |
| Product containing only botulinum toxin type B in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Botulinum toxin type B |
Inferred relationship |
Some |
1 |
| Product containing precisely botulinum toxin type B 5000 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Botulinum toxin type B |
Inferred relationship |
Some |
1 |
| Product containing precisely botulinum toxin type B 5000 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Botulinum toxin type B |
Inferred relationship |
Some |
1 |
| Product containing botulinum toxin type B in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Botulinum toxin type B |
Inferred relationship |
Some |
1 |
FHIR